This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Orthosiphon aristatus leaf
- DrugBank Accession Number
- DB15838
- Background
Not Available
- Type
- Biotech
- Groups
- Approved, Experimental
- Synonyms
- Arjak
- Cat's whiskers leaf
- Clerodendranthus spicatus leaf
- Clerodendranthus spicatus leaf extract
- Clerodendranthus stamineus leaf
- Clerodendrum spicatum leaf
- Java tea
- Java tea leaf
- Kidney tea
- Ocimum aristatum leaf
- Orthosiphon
- Orthosiphon aristatus leaf
- Orthosiphon aristatus leaf dry extract
- Orthosiphon aristatus var. aristatus leaf
- Orthosiphon leaf
- Orthosiphon spicatus leaf
- Orthosiphon stamineus leaf
- Orthosiphon stamineus leaf extract
- Orthosiphonis folium
- Shen cha leaf
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Florasun Orthosiphon Cap 250mg Capsule 250 mg / cap Oral Laboratoire Lalco Inc. 1994-12-31 2000-08-01 Canada 
Retention D'eau - Cap 250mg Capsule 250 mg / cap Oral Laboratoire Lalco Inc. 1997-01-20 2002-09-05 Canada
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- DSS8V86H3Y
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 1, 2 Unknown Status Treatment Diabetic Retinopathy (DR) 1 Not Available Completed Not Available Syndrome, Metabolic 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Capsule Oral 250 mg / cap - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at September 15, 2020 15:55 / Updated at September 20, 2020 16:22